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Autophagy-Lysosome Pathway in Renal Tubular Epithelial Cells is
Disrupted by Advanced Glycation End Products in Diabetic Nephropathy
W. J. Liu, T. T. Shen, H. L. Wu, H. F. Liu
Nephrology, Zhanjiang, China
Objective: Autophagy has been suggested to protect renal tubular epithelial
cells (TECs) from injury during diabetic nephropathy (DN). However, the
manner in which the autophagy-lysosome pathway is changed in this state
remains unclear.
Methods: In this study of DN, we investigated the autophagic activity and
lysosomal alteration in vivo and in vitro.
Results: We found that autophagic vacuoles and SQSTM1 positive proteins
accumulated in TECs from patients with DN and also in HK-2 cells treated
with advanced glycation end products (AGEs), the important factors that
involved in the pathogenesis of DN. In HK-2 cells, exposure to AGEs caused
a significant increase in autophagosomes, but a marked decrease in autoly-
sosomes. Furthermore, the lysosomal turnover of LC3-II was not observed
post AGEs treatment. Furthermore, lysosomal membrane permeabilization
(LMP) was triggered by AGEs during the progression of DN, which likely
resulted in a decrease in the enzymatic activity of cathepsin B (CB) and
CL, the defective acidification of lysosomes, and suppressed the degradation
of DQ-ovalbumin. Additionally, ubiquitinated proteins were co-localized
with SQSTM1 positive puncta and accumulated in HK-2 cells after exposure
to AGEs, indicating blocked degradation of SQSTM1 positive and ubiquiti-
nated aggregates.
Conclusion: Taken together, LMP and lysosomal dysfunction are triggered by
AGEs, which induce autophagic inactivation in TECs from patients with DN.
Disruption of autophagy-lysosome pathway should be focused when studying
the mechanisms underlying DN.http://dx.doi.org/10.1016/j.hkjn.2015.08.036
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Cdk5 Regulates ERK1/2/PPARg-mediated Renal Tubulointerstitial
Fibrosis in Diabetic Nephropathy
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Objectives: Cyclin-dependent kinase 5 (Cdk5) has been documented in
podocyte injuries in diabetic nephropathy (DN), however its role in renal
tubular epithelial cells has not been elucidated. This study aims to investi-
gate whether Cdk5 regulates tubulointerstitial fibrosis (TIF) via the extracel-
lular signal-regulated kinase 1/2 (ERK1/2)/peroxisome proliferator-
activated receptor gamma (PPRAg) pathway in DN.
Methods: Effects of activating or inhibiting Cdk5, ERK1/2 and PPARg
signaling on downstream gene expressions and epithelial-to-mesenchymal
transition (EMT) were investigated using in vitro and in vivo approaches. Ex-
pressions of related molecules were validated in 86 archival DN patient renal
biopsy samples and biological parameters were analyzed.
Results: In high glucose cultured normal rat kidney cells (NRK52E) cells, in-
hibition of Cdk5 kinase activity using roscovitine decreased the expression of
mesenchymal markers and the ability of cells to migrate and invade via
ERK1/2/PPARg pathway (Figure 1). In diabetic rat kidneys, inhibition of
Cdk5 kinase activity using roscovitine increased phosphorylation of ERK1/2
and PPARg leading to upregulation of E-cadherin but downregulation of
vimentin and collagen IV and improved TIF. Blood urine nitrogen (BUN),
serum creatinine and b2-microglobulin were decreased. In DN patients’
renal biopsy samples (Figure 2), the expression level of CDK5 and p35
were upregulated with increased phosphorylation of ERK1/2 and PPARg in
the late stage compared with early-stage DN. These changes were concom-
itant with decreased expression of E-cadherin but increased vimentin and
collagen IV with deteriorated TIF and elevated BUN, serum creatinine and
b2-microglobulin.
